Global Precision Nutrition Market Size, Trend & Opportunity Analysis Report, by Technology (Metabolomics, Genomics, Transcriptomics, Proteomics, Others), Application (Disease Management, General Health & Wellness, Weight Management, Sports Nutrition), Services Type (Genomics & Multi-omics Analysis services, Personalised plans & Subscription Services, Consulting Services, Digital Platforms, Institutional & wellness programs), End use (Healthcare provider, Research Institutes, Dietary supplement, Fitness & wellness companies, Direct-to-consumer), Supplement (Vitamins, Minerals, Probiotic, Herbal Supplement, Protein Supplements, Amino Acids, Enzymes, Others Supplements), and Forecast, 2025-2035
Global Precision Nutrition Market Size, Opportunity Analysis and Forecast, 2025-2035
Market Definition and Introduction
The Global Precision Nutrition Market was valued at USD 6.09 billion in 2024 and is predicted to surge to USD 34.25 billion by 2035, growing at an exceptional CAGR of 17.00% during the forecast period 2025-2035. These market trends are being driven by an apparent change in health-seeking behaviour in which personalised nutrition lies at the intersection of genomics, biochemistry, and lifestyle interpretation. These dietary regimes, gaining widespread acceptance among consumers, are based on scientific assessment and individualised using modern molecular-profiling tools.
Rise of chronic diseases, digital health establishment, and increasing health consciousness have allowed precision nutrition to rise as a formidable player in reestablishing how people navigate wellbeing and clinical conditions. These nutritional strategies expand on reducing generic diet plans, addressing gene expression, protein interactions, and metabolic feedback to provide unique, holistic health insights. Such a transition empowers consumers to make informed decisions based on data-backed recommendations, while pushing nutrition companies to innovate within the bounds of proteomics and metabolomics.
Integration of precision nutrition is being spearheaded by healthcare practitioners and research organisations alike. With the push towards preventive medicine gaining traction in governments and institutions worldwide, the rapid adoption of personalised nutrition for disease prevention-from diabetes and obesity to heart disease, is gaining steam. The precision nutrition market is being shaped by technological advances, reduced biomarker analysis costs, and AI-enabled digital health platforms that disrupt the food, health-data, and longevity interface proposition.
Recent Developments in the Industry
- In March 2024, Nestl- Health Science partnered with genomic testing startup GeneMate to co-develop a new line of DNA-based nutritional supplements, aiming to broaden its presence in the personalised wellness market.
- In September 2023, Amway launched its AI-powered Nutrilite Precision Pack platform across Asia-Pacific, allowing customers to receive customised supplement regimens based on personal biomarkers, lifestyle assessments, and genetic data.
- In June 2023, DSM-Firmenich announced a strategic alliance with GENEWAY to develop proteomic-based solutions for improving gut health and immunity, reflecting the growing interest in microbiome-targeted nutrition.
- In February 2023, Viome Life Sciences received FDA breakthrough device designation for its RNA-based precision nutrition platform, validating its therapeutic potential for chronic inflammatory diseases through dietary modulation.
Market Dynamics
Rising incidence of chronic diseases is reinforcing the need for personalised nutritional interventions.
The increasing worldwide prevalence of lifestyle-related chronic ailments-such as obesity, type 2 diabetes, and cardiovascular illnesses ushering in demand for personalised dietary solutions. Precision nutrition cuts down the onset and progression of diseases with an evidence-based way of customising food choices and supplement intake with respect to one's biochemical and genetic profiles, so that any nutritional intervention directly addresses the cause rather than merely seeking symptomatic relief.
Technological advancements in Omics and artificial intelligence are expediting the innovation-cum-commercialization panorama.
Such a renaissance within the market would entail attaining breakthroughs in transcriptomics, metabolomics, and machine learning to enhance the accuracy as well as the scalability of personalised nutrition models. These technologies should lead to an extremely deep phenotypic understanding and predictive analytics approach to empower operators to furnish useful dietary insights at a population scale, offering mass-market viability.
Consumer preference shifts toward data-driven health decisions fuel product adoption.
Backed by wearable devices, digital diagnostics, and wellness tracking platforms, modern-day consumers themselves are engaging in health optimisation through quantifiable means. This behavioural shift is fuelling the personalisation of nutrition as an additional lifestyle tool whereby supplement brands and digital health platforms are incentivised to build real-time feedback loops, adapting to changing biological
inputs and health goals.
Strategic Collaborations Between Healthcare and Nutrition Ecosystems Bolstering Market Expansion.
The fusion of clinical healthcare with consumer nutrition is giving rise to integrated service models. Nutrigenomics labs are tying in with hospitals, telemedicine, and fitness apps to provide end-to-end precision nutrition services from biomarker screening to customised supplement delivery, transforming all aspects of distribution frameworks and regulatory environments.
Policy support and institutional research driving awareness and scientific credibility.
Several governments and research institutions globally keen to recognise precision nutrition as a means of minimising healthcare costs and maximising population health outcomes, initiatives like the U.S. National Institutes of Health's Nutrition for Precision Health program are also aiding large-scale clinical validation efforts, giving rise to a foundation for policy integration and insurance coverage pathways.
Attractive Opportunities in the Market
- Expanding Genomic Sequencing - Wider accessibility to genetic testing drives adoption in preventive nutrition.
- Microbiome-targeted Products - Growing demand for gut health solutions fuels personalised formulations.
- AI-powered Meal Planning - Algorithms optimise diet based on ongoing biomarker feedback.
- Wearable-integrated Diet Solutions - Connected devices link physical activity, sleep, and dietary response.
- Proteomic-based Supplementation - Innovations targeting protein expression enhance health outcomes.
- Subscription-based Health Platforms - Personalised supplements delivered via monthly kits increase loyalty.
- Ageing Population Focus - Older adults seek longevity-oriented nutrition plans tailored to ageing biomarkers.
- Healthcare Integration - Collaboration with providers allows precision nutrition to enter clinical pathways.
Report Segmentation
By Technology: Metabolomics, Genomics, Transcriptomics, Proteomics, Others
By Application: Disease Management, General Health & Wellness, Weight Management, Sports Nutrition
By Services Type: Genomics & Multi-omics Analysis services, Personalised plans & Subscription Services, Consulting Services, Digital Platforms, Institutional & wellness programs
By End use: Healthcare provider, Research Institutes, Dietary supplement, Fitness & wellness companies, Direct-to-consumer
By Supplement: Vitamins, Minerals, Probiotics, Herbal Supplements, Protein Supplements, Amino Acids, Enzymes, Other Supplements
By Region: North America (U.S., Canada, Mexico), Europe (UK, Germany, France, Spain, Italy, Spain, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea, Rest of Asia-Pacific), LAMEA (Brazil, Argentina, UAE, Saudi Arabia (KSA), Africa Rest of Latin America)
Key Market Players: Nestl- Health Science, DSM-Firmenich, Viome Life Sciences, Amway, GENEWAY, Nutrigenomix, Xcode Life, DNAfit, DayTwo, Care/of
Report Aspects
Base Year: 2024
Historic Years: 2022, 2023, 2024
Forecast Period: 2025-2035
Report Pages: 293
Dominating Segments
Genomics Leads Precision Nutrition by Integrating with Clinical and Wellness Applications
Genomics commands a pivotal position within precision nutrition, with very specific utility regarding actionable insights inferred from individual genetic predisposition for nutrient metabolism, chronic disease predisposition, and fitness degree. High-throughput sequencing and bioinformatics instruments enable advanced precision nutrition, which is capable of generating input for optimal dietary management.
Disease Management Applications Experience Spike Due to the Growth of Chronic Conditions
Deepening realisation of personalised nutrition as delivery of cure and management, this division is expanding at a breakneck speed, treating
and curing pathologies like diabetes, obesity, and cardiovascular disease. Nutritional plans provide manna from genomics, metabolomics, and proteomic analyses for target- and ultimately lower-long-term healthcare costs. Upsurging health consumer awareness and insurance favourable towards preventive wellness programs further increase market horizons, sweetening the arena of disease management for precision nutrition.
Personalised Plans & Subscription Services Expand the Market's
Global Reach-Subscription-based dietary and wellness services were a key market driver, allowing continuous monitoring, feedback in real-
time, and nutrition strategies to adapt. Providers now proffer tailored solutions that touch the hearts of health-conscious consumers by utilising digital technologies, AI analytics, and multi-omics insights. With their scalability, these have penetrated the urban markets of Asia-
Pacific and North America, while promoting sustainable business models, banking on recurring revenue streams.
Protein and Probiotic Supplements Enhance Nutritional Efficacy
Functional supplements like protein and probiotics increasingly find application in precision nutrition to complement personalised diet plans that perform in parallel. They scavenge for metabolic health, microbiota performance, protection, and recuperation in sports and wellness contexts. Incorporating clinical validation and multi-omics criteria in design yields better efficacy in supplementation and consumer satisfaction for better market leadership and adoption.
Healthcare Provider Leads Adoption through Clinical Integration
Among all the precision nutrition adopters, hospitals, clinics, and research institutions are the forerunners by integrating genomics-driven dietary strategy into patient care and clinical trials, ensuring greater treatment effectiveness, good patient adherence, and positive clinical outcomes. Nursing partnerships are being lauded in driving nutrition-based interventions based on evidence, something that is driving product innovation between healthcare providers and nutrigenomics companies.
Key Takeaways
- Disease-centric applications are driving clinical integration of precision nutrition worldwide.
- Genomics remains the leading technology, unlocking DNA-based insights for preventive care.
- Proteomics and metabolomics are revolutionising how diet impacts protein expression and energy metabolism.
- Digital platforms and mobile diagnostics expand consumer reach in the personalised health space.
- Strategic partnerships between nutraceutical companies and biotech innovators drive product development.
- Asia-Pacific is emerging as a key growth region due to urban wellness trends and mobile health access.
- Wearables and AI tools personalise diet plans in real time, enhancing long-term engagement.
- Consumer interest in longevity and performance optimisation is reshaping wellness commerce.
Regional Insights
Rapid Growth of North America Precision Nutrition Market with Strong Genomics Infrastructure
North America, especially the U.S., contributes a large portion of the market due to its modern healthcare infrastructure, well-developed genomics facilities, and impressively high consumer awareness about personal health. The integration of multi-omics technologies in hospitals, fitness, and wellness centres, along with the huge investments in research and development, helps in the innovation and adoption. Government initiatives to promote preventive healthcare encourage even more adoption of precision nutrition for the management of clinical diseases and sports performance nutrition.
Europe, Soon To Be The Green And Regulatory Balanced Precision Nutrition Hub
Europe is well in pursuit of precision nutrition services due to a close fit of the regulations with the EFSA and data protection standards at local levels. Major countries such as Germany, France, and the UK are aligning clinical research with nutrigenomics innovations and the development of evidence-based functional supplements. Eco-certifications, clean-label supplements, and consumer transparency have prompted the adoption in health-conscious markets, creating pathways for companies to improve compliance frameworks.
Asia-Pacific Exhibits Rapid Growth Backed by Industrialisation and Healthcare Investment
With growing disposable incomes, urbanisation, and increasing investments in the healthcare and biotechnology sectors, the Asia Pacific is expected to surge remarkably. Thus, developing genomics laboratories, wellness platforms, and direct-to-consumer offerings of precision nutrition rapidly scales in countries such as China, India, and South Korea. This fierce growth of e-commerce and mobile health applications globally, along with government initiatives in preventive healthcare, makes it appear like a high-potential market for personalised nutrition
interventions and supplements.
Emerging Potential of LAMEA through Rising Health Consciousness
The rising health consciousness, growing consumption of dietary supplements, and exercise-oriented lifestyles have made Latin America, the Middle East, and Africa emerging regions of precision nutrition. For instance, Brazil, the UAE, and South Africa are all investing in clinical and wellness programs, further driving appropriateness with increased subscription-based dietary services. Although relatively nascent, these regions will surely present bright opportunities in the future through digital health platforms and integrative multi-omics solutions.
Key Benefits for Stakeholders
- The report offers a quantitative assessment of market segments, emerging trends, projections, and market dynamics for the period 2024 to 2035.
- The report presents comprehensive market research, including insights into key growth drivers, challenges, and potential opportunities.
- Porter's Five Forces analysis evaluates the influence of buyers and suppliers, helping stakeholders make strategic, profit-driven decisions and strengthen their supplier-buyer relationships.
- A detailed examination of market segmentation helps identify existing and emerging opportunities.
- Key countries within each region are analysed based on their revenue contributions to the overall market.
- The positioning of market players enables effective benchmarking and provides clarity on their current standing within the industry.
- The report covers regional and global market trends, major players, key segments, application areas, and strategies for market expansion.
Frequently Asked Question(FAQ) :
Genomics is the leading technology within the market. It provides actionable insights by analyzing an individual's genetic predisposition for nutrient metabolism and chronic disease risks. High-throughput sequencing and bioinformatics are essential tools currently driving this segment’s integration into clinical and wellness applications.
The market is primarily driven by the rising prevalence of lifestyle-related chronic diseases (such as obesity and type 2 diabetes), rapid advancements in "Omics" technologies and AI, a consumer shift toward data-driven health decisions, and increasing government support for preventive medicine.
Disease management is experiencing a significant spike in adoption as personalized nutrition is increasingly viewed as a tool for treatment and management rather than just wellness. By utilizing genomics and metabolomics, these nutritional plans help address the root causes of pathologies like cardiovascular disease, ultimately aiming to lower long-term healthcare costs.
AI is a critical enabler for scalability and accuracy. It powers digital health platforms that provide real-time feedback, optimizes meal planning based on ongoing biomarker data, and enables predictive analytics to deliver useful dietary insights at a population scale.
North America currently leads the market due to its advanced healthcare infrastructure and high consumer awareness. However, the Asia-Pacific region is emerging as a high-potential growth hub, driven by increasing disposable incomes, rapid urbanization, and significant investments in biotechnology in countries like China and India.
Key obstacles include the high cost and complexity of multi-omics testing infrastructure, a lack of standardized global regulatory guidelines, concerns regarding the privacy of personal biomarker data, and a shortage of professional training for integrating nutrition with genomics.
Subscription-based dietary and wellness services are a key driver for market reach. These models allow for continuous monitoring and adaptive nutrition strategies. By utilizing AI and multi-omics insights, providers offer tailored solutions that promote customer loyalty and create sustainable, recurring revenue streams.
In 2024, Nestlé Health Science partnered with GeneMate for DNA-based supplements. In 2023, Amway launched an AI-powered Nutrilite Precision Pack in Asia-Pacific, and Viome Life Sciences received an FDA breakthrough device designation for its RNA-based nutrition platform, validating the therapeutic potential of the industry.
Significant opportunities lie in the development of microbiome-targeted products, the integration of precision nutrition into clinical pathways through healthcare provider partnerships, the creation of wearable-integrated diet solutions, and the development of longevity-oriented nutrition plans for the aging population.
